Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Remimazolam Tosilate for General Anesthesia on Prognosis After Bladder Cancer Surgery: a Randomized Controlled Trial

NCT04532606 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT04532606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04532606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Remimazolam Tosilate for General Anesthesia on Prognosis After Bladder Cancer Surgery: a Randomized Controlled Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
February 5, 2021
Completion date
October 31, 2026
Enrollment
1,128 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

benzodiazepines, bladder cancer, cancer recurrence, delirium, surgery